CHICAGO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Sprout Social (Nasdaq: SPT), an industry-leading provider of cloud-based social media management software, today announced a new wave of features and partnerships designed to help brands lead in the Social Intelligence era. As customers increasingly turn to platforms like TikTok and Bluesky for discovery, product recommendations, and real-time conversation, the ability to capture sentiment early and act fast has become essential. Sprout’s latest release will deliver powerful new TikTok Listening, expanded Bluesky publishing and reporting, alongside new creator collaboration tools, all built to turn every social interaction into insight, action, and measurable business impact.

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- While brands are celebrating AI-driven efficiency gains in customer experience (CX), a significant gap exists between their internal benefits and the often underwhelming service that consumers are actually experiencing. According to Verizon’s CX Annual Insights report, the future of CX isn't just about implementing AI, but about strategically integrating it to amplify human connections and address core customer frustrations.

- Enrollment to-date of 52 patients in the ongoing Halneuron^® Phase 2b Trial -

FREMONT, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Interlink Electronics, Inc. (Nasdaq: LINK) (“Interlink” or the “Company”), a global leader in sensor technology and printed electronic solutions, today reported results for the second quarter ended June 30, 2025.

Includes $6.0 million in cash gross proceeds to the Company

MediWound Announces New EscharEx^® Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers

MCLEAN, Va., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”), a leading provider of cybersecurity and IT solutions, today announced that it plans to file its Quarterly Report on Form 10-Q for the second quarter ended June 30, 2025 with the U.S. Securities and Exchange Commission on Thursday, August 14, 2025. Ahead of the filing, the Company is highlighting its significant accomplishments, including a transformative alliance with IQSTEL, an innovative cryptocurrency strategy through Cycurion Crypto, and other key partnerships that strengthen its position for future growth.

Company achieves gross profit increase of 18.3% to $3.9 million

New York, N.Y., Aug. 13, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced its attendance at several upcoming industry focused investor events.

HUZHOU CITY, China, Aug. 13, 2025 (GLOBE NEWSWIRE) -- LZ Technology Holdings Limited (NASDAQ: LZMH) (“LZMH” or the “Company”), a leading provider of information technology and advertising services, today announced that all of its principal shareholders have entered into agreements with the Company to extend their lock-up restrictions until August 31, 2026. This extension follows the original 180-day lock-up period established in connection with the Company’s initial public offering completed in February 2025.

Strategic COO and CFO Appointments Enhance Operational and Financial Capabilities

Strategic collaboration targets US$100M in assets under management through algorithmic Bitcoin trading

America’s Patriotic Beer - American Rebel Light Expands Distribution Across the Mid-Western USA into Minnesota

LAS VEGAS, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Xtreme One Entertainment, Inc. (OTC: XONI), the parent company of XFC Global, and Borroka MMA have announced a landmark partnership to co-promote XFC 53, set for Saturday, September 20^th, 2025, at The Theater at Virgin Hotels in Las Vegas. 

SOUTH SAN FRANCISCO, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that dosing in the Phase 2 B-SUPREME study of its investigational compound ALG-000184 has been initiated in subjects with chronic hepatitis B virus (HBV) infection.